Header Logo

Connection

Leslie Shaw to Liver Diseases

This is a "connection" page, showing publications Leslie Shaw has written about Liver Diseases.
Connection Strength

0.033
  1. Shaw LM, Str?mme JH, London JL, Theodorsen L. International Federation of Clinical Chemistry. Scientific Committee, Analytical Section. Expert Panel on Enzymes. IFCC methods for measurement of enzymes. Part 4. IFCC methods for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: amino acid gamma-glutamyltransferase, EC 2.3.2.2]. IFCC Document, Stage 2, Draft 2, 1983-01 with a view to an IFCC Recommendation. Clin Chim Acta. 1983 Dec 30; 135(3):315F-338F.
    View in: PubMed
    Score: 0.012
  2. Tietz NW, Rinker AD, Shaw LM. International Federation of Clinical Chemistry. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). IFCC Document Stage 2, Draft 1, 1983-03 with a view to an IFCC Recommendation. Clin Chim Acta. 1983 Dec 30; 135(3):339F-367F.
    View in: PubMed
    Score: 0.012
  3. Azzazy HM, Duh SH, Maturen A, Schaller E, Shaw L, Grimaldi R, Shock G, Christenson RH. Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors. Clin Chem. 1997 Sep; 43(9):1635-40.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.